The PDE6C gene helps the cone cells in the retina turn light into clear, detailed, color vision. If the PDE6C gene does not work properly, cone cells may not pass along visual signals in the usual way, which can lead to blurry central vision, trouble seeing colors, light sensitivity, and eye movements that often begin in infancy or childhood. Some people with variants in the PDE6C gene are diagnosed with achromatopsia or a cone related retinal condition.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes hold the instructions for producing proteins, which are the parts of cells that do the work. Others mainly help regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a more in depth look at this topic, you can find more in the LearnHub.
Overview
PDE6CGene function
What if the gene works
The PDE6C gene helps cone cells in the retina turn light into visual signals. This supports sharp central vision, color vision, and seeing well in daylight.
Risk
What if the gene does not work
Variants in the PDE6C gene can impair retinal cone cells, causing achromatopsia or cone dystrophy with poor color vision, light sensitivity, and reduced vision. Milder and more severe variants may change when symptoms start and how much vision is affected.
Treatment
What does that mean for your treatment
At present, no treatment or management approach specific to a pathogenic variant in the PDE6C gene is established in clinical guidelines. The PDE6C gene is being studied as a retinal gene therapy target for PDE6C related cone conditions, but this remains investigational.
Conditions associated with PDE6C
Gene function
What if the gene works
Seeing color, fine detail, and bright daylight depends on quick chemical signals inside cone cells in the retina. The PDE6C gene gives cone cells instructions for a protein that helps manage those signals. When the PDE6C gene is active, cone cells can turn incoming light into clear messages for the brain.
One of the roles of the PDE6C gene is to help cone cells respond after they detect light. This is central to how the PDE6C gene helps cone cells turn light into vision.
Its protein lowers the level of cGMP (a small messenger molecule) inside cone cells during visual signaling. This helps the light response stay precise instead of lingering too long.
PDE6C activity supports the cone cells used most in bright light. This helps the eye handle sharp detail and color in everyday settings, like reading signs or recognizing faces outdoors.
Cone cells need to recover quickly so they can keep up as light changes from moment to moment. The PDE6C gene supports that reset process, helping vision stay responsive in changing daylight.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not produce any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant changes how a gene works to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PDE6C gene can change the cone cell enzyme’s shape, stability, or ability to break down cGMP, a signal molecule in the retina. In PDE6C gene variants linked to vision loss, milder changes may leave some enzyme activity, while more severe variants can largely switch it off. Poor cGMP control disrupts cone cell signaling and may stress these cells over time, which is linked to earlier or more marked achromatopsia or cone dystrophy.
How variants are linked to conditions
Pathogenic variants in the PDE6C gene cause achromatopsia, an inherited eye condition present from early life that affects color vision, sharp central vision, and comfort in bright light. Variants in the PDE6C gene have also been linked to cone dystrophy in some families, which can bring similar vision problems and may worsen over time. These are rare inherited retinal conditions rather than a risk signal for common eye disease.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In other situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For PDE6C-related vision conditions, risk is mainly set by the gene changes you inherit, especially when both copies of the gene are affected. Family history and whether both biological parents carry a PDE6C change are the main factors, and there is not enough evidence to say that lifestyle changes lower this inherited risk.
Inheritance of PDE6C variants
PDE6C-related conditions are inherited in an autosomal recessive pattern. In practical terms, how PDE6C gene variants are inherited usually means a person develops the condition after receiving one altered copy of the PDE6C gene from each parent. Parents who each carry one variant are often unaffected, and with each pregnancy there is a 25% chance the child inherits both variants, a 50% chance the child is a carrier, and a 25% chance the child inherits neither variant. This pattern applies to the well-established vision conditions linked to the PDE6C gene.
What does my PDE6C result mean for my family?
For families with a disease-causing change in the PDE6C gene, relatives may also carry the same change even if they do not have vision problems. Brothers and sisters may be affected or may be carriers, and parents are usually carriers. Other close relatives, such as aunts, uncles, and cousins, may also carry the family’s PDE6C change.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the PDE6C gene, labs use genetic testing for PDE6C variants on a blood or saliva sample. The test reads the DNA sequence and looks for variants that may help explain cone related vision problems or support the diagnosis of an inherited retinal condition.
When should I consider getting a genetic test?
Consider genetic testing for the PDE6C gene if someone has lifelong poor color vision, strong light sensitivity, blurry central vision, or eye shaking starting in infancy or early childhood. It can also be helpful when these vision problems run in the family, because changes in PDE6C are a known cause of some inherited cone-related vision conditions, including achromatopsia.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies by the condition and by the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as response to medications, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. The same medication may work well for one person, have less effect in another, or cause more side effects because bodies absorb, break down, or respond to drugs in different ways. These differences are common and can influence both how well a treatment works and how sensitive someone is to it. Pharmacogenetics studies these inherited differences to help explain why medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect how people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how the body handles a drug and how strong its effects may be. This information can support more informed, personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the PDE6C gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any questions about side effects, new symptoms, or treatment concerns are best discussed with your doctor or pharmacist.